Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
APC regulator of WNT signaling pathway | 0.373 | 0.962 | 1.00 |
|
group | 0.900 | None | 0.982 | 17 | 9 | 1990 | 2019 | ||||||||
|
tumor protein p53 | 0.236 | 0.962 | 0.53 |
|
group | 0.700 | None | 0.989 | 2 | 67 | 1991 | 2018 | ||||||||
|
catenin beta 1 | 0.303 | 0.885 | 1.00 |
|
group | 0.700 | None | 0.985 | 1 | 6 | 1997 | 2019 | ||||||||
|
B-Raf proto-oncogene, serine/threonine kinase | 0.319 | 0.846 | 1.00 |
|
group | 0.500 | None | 0.978 | 33 | 10 | 2002 | 2019 | ||||||||
|
KRAS proto-oncogene, GTPase | 0.320 | 0.923 | 7.9E-04 |
|
group | 0.500 | None | 0.983 | 20 | 12 | 1990 | 2019 | ||||||||
|
SMAD family member 4 | 0.401 | 0.808 | 1.00 |
|
group | 0.500 | None | 1.000 | 8 | 8 | 1996 | 2016 | ||||||||
|
epidermal growth factor receptor | 0.295 | 0.885 | 0.37 |
|
group | 0.500 | None | 0.976 | 1 | 1 | 2003 | 2019 | ||||||||
|
phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha | 0.292 | 0.923 | 1.00 |
|
group | 0.490 | None | 1.000 | 16 | 32 | 2004 | 2019 | ||||||||
|
NRAS proto-oncogene, GTPase | 0.390 | 0.808 | 0.49 |
|
group | 0.410 | None | 1.000 | 9 | 6 | 2006 | 2016 | ||||||||
|
DNA polymerase epsilon, catalytic subunit | 0.526 | 0.731 | 8.0E-27 |
|
group | 0.400 | None | 1.000 | 1 | 3 | 2013 | 2016 | ||||||||
|
AKT serine/threonine kinase 2 | 0.474 | 0.769 | 0.64 |
|
group | 0.300 | None | 1.000 | 2 | 1 | 2002 | 2014 | ||||||||
|
HRas proto-oncogene, GTPase | 0.378 | 0.885 | 8.0E-02 |
|
group | 0.200 | None | 1.000 | 3 | 8 | 1985 | 2016 | ||||||||
|
cyclin dependent kinase inhibitor 2A | 0.300 | 0.885 | 0.39 |
|
group | 0.200 | None | 1.000 | 1 | 2 | 2003 | 2016 | ||||||||
|
erb-b2 receptor tyrosine kinase 2 | 0.328 | 0.923 | 6.0E-03 |
|
group | 0.200 | None | 1.000 | 1 | 7 | 2002 | 2016 | ||||||||
|
EPH receptor B2 | 0.374 | 0.846 | 1.00 |
|
group | 0.190 | None | 1.000 | 1 | 1 | 2001 | 2014 | ||||||||
|
phosphatase and tensin homolog | 0.305 | 0.923 | 0.26 |
|
group | 0.160 | None | 1.000 | 11 | 5 | 2004 | 2019 | ||||||||
|
Raf-1 proto-oncogene, serine/threonine kinase | 0.418 | 0.885 | 0.85 |
|
group | 0.130 | None | 1.000 | 1 | 1 | 2002 | 2016 | ||||||||
|
GNAS complex locus | 0.420 | 0.885 | 0.68 |
|
group | 0.130 | None | 1.000 | 1 | 2 | 2014 | 2019 | ||||||||
|
mitogen-activated protein kinase kinase 1 | 0.439 | 0.846 | 0.90 |
|
group | 0.120 | None | 1.000 | 1 | 4 | 2005 | 2016 | ||||||||
|
F-box and WD repeat domain containing 7 | 0.465 | 0.808 | 1.00 |
|
group | 0.120 | None | 1.000 | 1 | 7 | 2004 | 2016 | ||||||||
|
beta-2-microglobulin | 0.447 | 0.846 | 0.56 |
|
group | 0.110 | None | 1.000 | 1 | 3 | 2007 | 2016 | ||||||||
|
protein tyrosine phosphatase non-receptor type 11 | 0.385 | 0.923 | 1.00 |
|
group | 0.110 | None | 1.000 | 1 | 3 | 2016 | 2016 | ||||||||
|
ras homolog family member A | 0.502 | 0.808 | 0.60 |
|
group | 0.110 | None | 1.000 | 1 | 2 | 2008 | 2016 | ||||||||
|
mechanistic target of rapamycin kinase | 0.343 | 0.885 | 1.00 |
|
group | 0.110 | None | 1.000 | 1 | 2 | 2010 | 2016 | ||||||||
|
erb-b2 receptor tyrosine kinase 3 | 0.448 | 0.808 | 1.7E-15 |
|
group | 0.110 | None | 1.000 | 1 | 1 | 2011 | 2016 |